Viatris (VTRS) announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus, or SLE. The ...

Viatris disclosed that its manufacturing facility in Indore, India, was issued a warning letter from the FDA, which banned 11 products that are produced at the site from being imported into the U ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Global pharma major Viatris has been issued a warning letter and an alert barring import of a clutch of products from its oral finished dose manufacturing plant in Indore, Madhya Pradesh ...

06:51 EST Viatris (VTRS) doesn’t see FDA warning impacting current 2024 financial guidance Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

Viatris (Nasdaq: VTRS) has disclosed that its oral finished-dose manufacturing facility in Indore, India, is subject to action from the US regulator, after an inspection earlier this year. The US Food ...

The US FDA has restricted imports of 11 products from Viatris' Indore facility in India due to violations of federal requirements found during an inspection. The action affects oral finished doses.

Beyond logos, create business cards, social media kits, favicons, and more. Download high-resolution PNG, JPEG, and vector files, and get brand guidelines for fonts and colors. Make unlimited changes ...

Novartis and Viatris have become the latest pharma companies to be named in lawsuits claiming that they profited from the unlawful use of HeLa cells derived from cells taken from a cancer patient ...